Clinical Proteomics

Papers
(The H4-Index of Clinical Proteomics is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Comparative proteomic analysis of glomerular proteins in primary and bucillamine-induced membranous nephropathy67
Changes of serum IgG glycosylation patterns in rheumatoid arthritis39
Recent progress in mass spectrometry-based urinary proteomics26
Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue23
The relationship between serum astroglial and neuronal markers and AQP4 and MOG autoantibodies22
CSF levels of brain-derived proteins correlate with brain ventricular volume in cognitively healthy 70-year-olds21
Integrative omics reveals subtle molecular perturbations following ischemic conditioning in a porcine kidney transplant model21
Proteome profiling of cutaneous leishmaniasis lesions due to dermotropic Leishmania donovani in Sri Lanka21
Data-independent acquisition mass spectrometry in severe rheumatic heart disease (RHD) identifies a proteomic signature showing ongoing inflammation and effectively classifying RHD cases20
Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay20
Correction: Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients19
Proteomic alteration of endometrial tissues during secretion in polycystic ovary syndrome may affect endometrial receptivity18
Serum proteomics for the identification of biomarkers to flag predilection of COVID19 patients to various organ morbidities18
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer’s disease biomarkers18
Mass spectrometry quantifies target engagement for a KRASG12C inhibitor in FFPE tumor tissue17
Proteomic characteristics and diagnostic potential of exhaled breath particles in patients with COVID-1916
0.016788959503174